Providence research from Northern California locations.


Submissions from 2021


Leveling the Playing Field: Accounting for Academic Productivity During the COVID-19 Pandemic., Vineet M Arora, Charlie M Wray, Avital Y O'Glasser, Mark Shapiro, and Shikha Jain


Open-label, phase II study of ladiratuzumab vedotin (LV) for castration-resistant prostate cancer (SGNLVA-005, trial-in-progress)., Amna Falak Sher, Justine Yang Bruce, Nashat Y. Gabrail, Ian Churchill Anderson, Anna Patrikidou, Rachel E Sanborn, Jae Yong Cho, Arielle Shebay Lee, Jong-Seok Lee, Louise M. Nott, Do-Youn Oh, Sang Cheul Oh, Sung Yong Oh, Yinghui Wang, Zejing Wang, and Troy H. Guthrie